Syndax Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Syndax Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | SNDX | Q1 | -$0.59 | -$0.99 | — | — | $0.00 | — | — | — | Get Alert |
02/27/2024 | PM | SNDX | Q4 | -$0.62 | -$0.99 | -$1.00 | -1.01% | $0.00 | — | $0.00 | — | Get Alert |
11/02/2023 | PM | SNDX | Q3 | -$0.58 | -$0.78 | -$0.73 | 6.41% | $0.00 | — | $0.00 | — | Get Alert |
08/03/2023 | PM | SNDX | Q2 | -$0.62 | -$0.73 | -$0.64 | 12.33% | $0.00 | — | $0.00 | — | Get Alert |
05/08/2023 | PM | SNDX | Q1 | -$0.63 | -$0.60 | -$0.59 | 1.67% | $0.00 | $430.00K | $0.00 | -100.00% | Get Alert |
02/28/2023 | PM | SNDX | Q4 | $1.81 | -$0.65 | -$0.62 | 4.62% | $126.58M | $370.00K | $0.00 | -100.00% | Get Alert |
11/03/2022 | PM | SNDX | Q3 | -$0.40 | -$0.63 | -$0.58 | 7.94% | $12.38M | $750.00K | $0.00 | -100.00% | Get Alert |
08/08/2022 | PM | SNDX | Q2 | -$0.44 | -$0.67 | -$0.62 | 7.46% | $379.00K | $1.37M | $0.00 | -100.00% | Get Alert |
05/09/2022 | PM | SNDX | Q1 | -$0.54 | -$0.63 | -$0.63 | 0.00% | $379.00K | $2.13M | $0.00 | -100.00% | Get Alert |
03/01/2022 | PM | SNDX | Q4 | -$0.44 | $0.28 | $1.81 | 546.43% | $380.00K | $58.68M | $126.58M | 115.71% | Get Alert |
11/15/2021 | PM | SNDX | Q3 | -$0.46 | -$0.23 | -$0.40 | -73.91% | $379.00K | $29.35M | $12.38M | -57.84% | Get Alert |
08/09/2021 | PM | SNDX | Q2 | -$0.42 | -$0.71 | -$0.44 | 38.03% | $379.00K | $220.00K | $379.00K | 72.27% | Get Alert |
05/11/2021 | PM | SNDX | Q1 | -$0.56 | -$0.65 | -$0.54 | 16.92% | $379.00K | $220.00K | $379.00K | 72.27% | Get Alert |
03/08/2021 | PM | SNDX | Q4 | -$0.44 | -$0.49 | -$0.44 | 10.20% | $380.00K | $200.00K | $380.00K | 90.00% | Get Alert |
11/02/2020 | PM | SNDX | Q3 | -$0.41 | -$0.10 | -$0.46 | -360.00% | $379.00K | $16.04M | $379.00K | -97.64% | Get Alert |
08/06/2020 | PM | SNDX | Q2 | -$0.47 | -$0.45 | -$0.42 | 6.67% | $379.00K | $400.00K | $379.00K | -5.25% | Get Alert |
05/07/2020 | PM | SNDX | Q1 | -$0.53 | -$0.51 | -$0.56 | -9.80% | $379.00K | $840.00K | $379.00K | -54.88% | Get Alert |
03/03/2020 | PM | SNDX | Q4 | -$0.70 | -$0.43 | -$0.44 | -2.33% | $380.00K | $370.00K | $380.00K | 2.70% | Get Alert |
11/07/2019 | PM | SNDX | Q3 | -$0.68 | -$0.47 | -$0.41 | 12.77% | $379.00K | $370.00K | $379.00K | 2.43% | Get Alert |
Syndax Pharmaceuticals (SNDX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $-1.00, which missed the estimate of $-0.99.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.